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Effect of leukocyte stimulation on rabbit immune complex glomerulo-
nephritis. Phytohemagglutinin (PHA), a leukocyte mitogen, induces a
lymphocyte and blast cell glomeruionephritis in rat renal aliografts (Cell
Immunol 13:146, 1974). The aim of this study was to assess whether
PHA similarly enhances rabbit monocyte-dependent experimental,
acute immune complex glomerulonephritis, and whether this effect is
associated with local release of interleukin-l (IL-l) and tumor necrosis
factor (TNF). Rabbits with experimental acute serum sickness (AcSS:
Group I) had focal proliferative and exudative glomerulonephritis with
immune deposits, scattered subepithelial electron-dense deposits
(humps), mild and transient proteinuria, normal creatinine clearance
and slightly increased production of IL-I and TNF from isolated
glomeruli. Rabbits with AcSS and injected with PHA (Group II)
developed severe lymphocyte and blast cell glomerulonephritis with
diffuse endothelial damage; immune deposits were significantly re-
duced, focal subepithelial electron-dense deposits were absent, protein-
uria was increased, creatinine clearance was decreased and production
of IL-l and TNF was markedly augmented as compared to rabbits in
Group I. Rabbits with AcSS and injected with IL-lp and TNFa (Group
V) had lesions comparable to those seen in Group II. These results
show that PHA, IL-l and TNF enhance the severity of acute immune
complex glomerulonephritis, presumably by activating glomerular en-
dothelial and mesangial cells and resident or infiltrated leukocytes.
Development of localized infections is occasionally associ-
ated with enhancement of immunologically-mediated injury
elsewhere in the body.
Infections may provoke relapses or exacerbation of glomer-
ulonephntis [1—4] and allograft rejection [5]. A similar enhanc-
ing effect was observed when the plant lectin phytohemagglu-
tinin (PHA)—a leukocyte mitogen [61—was injected into rats
with renal allografts. A lymphocyte and blast cell glomerulone-
phritis, characterized by interaction of activated lymphocytes
with the activated endothelium, developed in the grafts but not
in the native kidneys [7]. Subsequent studies have convincingly
shown that cell-mediated hypersensitivity may exert a role in
the pathogenesis of experimental and human glomerulonephri-
tis [8, 9]. The aim of the present study was to assess whether
PHA similarly enhances the severity of experimental acute
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immune complex glomerulonephntis in the rabbit, and whether
this effect is associated with a local release of the polypeptide
mediators interleukin-l (IL-i) and tumor necrosis factor (TNF).
Methods
Animals
New Zealand White rabbits of both sexes weighing from 2 to
2.5 kg were used.
Induction of acute serum sickness
Fifty-six rabbits received a single intravenous (i.v.) injection
of 250 mg/kg body weight of bovine serum albumin (crystallized
BSA, Behringwerke A.F., Marburg, FRG) associated with 10
g of Escherichia coli lipopolysaccharide (LPS) (Sigma Chem-
ical Company, St. Louis, Missouri, USA) [10].
To enhance the incidence of acute serum sickness (AcSS), 1
mg/kg of body weight of BSA in complete Freund's adjuvant
was administered subcutaneously three days before the intra-
venous injection of BSA [11]. The study included only rabbits
that developed AcSS (41 rabbits, 73% of injected rabbits) as
judged by glomerular immune deposit, detected by immunoflu-
orescence microscopy technique, and demonstration of circu-
lating anti-BSA antibodies after antigen elimination [11]. Free
antibodies were determined by immunoprecipitation [12].
Twenty-four rabbits injected only with complete Freund's
adjuvant and three days later with saline containing 10 j.g of
Escherichia coli LPS were used as controls.
Protocol of the experiments
After injection of BSA, rabbits were randomly assigned to
five groups. Group I included 11 rabbits with AcSS, without
additional treatment. Group II consisted of 10 rabbits with
AcSS and injected i.v. with PHA (Wellcome Diagnostics,
Hartford, UK) in a single dose of 0.5 mg/kg, seven days after
the i.v. injection of BSA. Group III included 10 rabbits with
AcSS, injected with human recombinant tumor necrosis fac-
tor-a (TNFa) (from Dr. Tatsuro Nishihara, Suntory Institute
for Biomedical Research, Osaka, Japan; specific activity, 5 X
i07 U/mg protein). The rabbits received a single i.v. injection of
1 pg/kg TNFa seven days after the i.v. injection of BSA. Group
IV was composed of five rabbits with AcSS, injected with
human recombinant interleukin-1/3 (IL-1J3) (Istituto Sclavo,
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Siena, Italy; specific activity 5.8 x 106 U/mg protein). The
rabbits received a single i.v. injection of 1 pg/kg IL-13 seven
days after the i.v. injection of BSA. Group V included five
rabbits with AcSS, injected i.v. with TNFa and IL-1/3 given in
single doses of 1 .tg/kg TNFa and 1 j.g/kg IL-l/3, seven days
after the i.v. injection of BSA.
Five groups of rabbits were used as controls, All these
animals were injected with complete Freund's adjuvants, and
three days later received a single i.v. injection of 1 ml of
isotonic saline and were divided as follows: five rabbits re-
ceived saline only (Group VI); seven days after the injection of
isotonic saline 10 rabbits were injected i.v. with a single dose of
0.5 mg/kg PHA (Group VII); five rabbits were injected i.v. with
a single dose of 1 pg/kg TNFr (Group VIII); four rabbits were
injected i.v. with a single dose of 1 pg/kg IL-1/3 (Group IX); and
five rabbits were injected i.v. with single doses of 1 pg/kg TNFa
and IL-lp (Group X).
Protein excretion was measured before the i.v. injection of
BSA (day 0) and at days 6, 8, 10, 12, 15. In rabbits of Groups I
and II protein excretion was repeatedly measured until the time
of sacrifice (day 30).
Creatinine clearance was measured in rabbits of Groups I and
II at day 0 and at days 10, 15 and 30. Serum complement was
measured in rabbits of Groups I and II at day 0 and at days 7 and
10 as CH5O activity [13]. In rabbits of Groups Ito VI, fragments
of renal tissue were obtained by surgical biopsy performed
under anesthesia at days 8, 10, 12, 15, and in four rabbits of
Groups I and II at day 30. In rabbits of Groups VII to X
fragments of renal tissue were obtained at days 0, 1, 2 and at
sacrifice, three days after the injections of cytokines. Five
rabbits in Groups I and II were nephrectomized at day 10, and
glomeruli were isolated to measure the production of TNF and
IL-l.
Histological, immunohistological and cytochemicalstudies
Fragments of renal tissue obtained by biopsy or at sacrifice
were processed as follows: part of tissue was fixed in 10%
buffered formalin and embedded in paraffin. Sections cut at 3
jsm and stained with hematoxylin and eosin or with periodic
acid-Schiff (PAS) reagent were studied by light microscopy.
Other sections, obtained from frozen tissue cut with a cryostat,
were stained for non-specific esterase activity [14, 15]. The
severity and extent of glomerular lesions were blindly and
independently evaluated by two investigators selecting four
parameters: hypercellularity; infiltration of polymorphonuclear
leukocytes (PMN); infiltration of cells positive for non-specific
esterase; fibrin thrombi and fibrinoid necrosis. In addition, the
number of tubular casts was considered. Glomerular hypercel-
lularity, fibnn thrombi, fibrinoid necrosis and tubular casts were
evaluated by a semi-quantitative method of renal histology
using a grading scale from 0, normal, to 5, maximum lesions
[16]. The number of PMN and monocyte/macrophages was
assessed by counting the total numbers of PMN and non-
specific esterase-positive cells in 10 randomly-selected glomer-
uli divided by the number of glomeruli. A second part of the
tissue was snap-frozen in liquid nitrogen and processed for
immunofluorescence microscopy. Fluorescein-conjugated anti-
bodies to rabbit IgG and C3, and to BSA were purchased from
Cappel Laboratories (Malvern, Pennsylvania, USA). Staining
of sections and appropriate controls were performed as previ-
ously described [17]. The amount and extent of fluorescence
were assessed in a minimum of six glomeruli and was graded on
a scale from 0 to 3. The intensity of immune deposits in figure
4 was expressed as average sum of scores given to all sections
of renal biopsies from days 8 to 15 stained for rabbit IgG, C3,
and BSA. A third part of tissue was fixed in a mixture of
paraformaldehyde and glutaraldehyde [18], post-fixed in os-
mium tetroxide and embedded in Epon 812. Thin sections,
stained with uranyl acetate and lead citrate were examined with
a JEOL IOOS electron microscope.
Measurement of proteinuria and creatinine clearance
Twenty-four hour urines were collected in metabolic cages.
The protein concentration was measured by biuret method [19].
The creatinine clearance was calculated by measuring creati-
nine concentration in urine and plasma by the alkaline picrate
method [201.
Production of TNF and IL-I from isolated glomeruli
After kidney perfusion with 100 ml of sterile isotonic saline,
glomeruli were isolated by sieving using successively 60, 150,
200 m mesh stainless steel screens as previously described
[21]. Glomerular preparations assessed by light microscopy
exhibited less than 5% of tubular contamination. Glomeruli
were counted, resuspended (10,000 glomeruli/mI) in RPMI 1640
supplemented with 100 U/mI penicillin, 100 g/ml streptomycin
(Gibco, Glasgow, UK), and 10% fetal calf serum (Gibco), and
incubated with or without 1 g/ml LPS for 24 hours at 37°C in
95% 02 and 5% CO2 atmosphere. All reagents used contained
less than 0.2 pg endotoxin/mI by the Limulus assay (Sigma
Chemical Co., St Louis, Missouri, USA). At the end of the
incubation period, the supernatants were centrifuged at 100 g
and the glomeruli were removed in order to measure the
proteins by Lowry method [22]. The amount of TNF and IL-l
was measured directly in the supernatants and after chromato-
graphic purification on a Sephacryl S200 HR column (Pharma-
cia, Uppsala, Sweden). One milliliter of 20-fold concentrated
medium was applied to 1.6% cm Sephacryl S200 HR calibrated
with the following molecular weight markers (Biorad, Rich-
mond, California, USA): ferritin (molecular wt 480,000); BSA
(molecular wt 67,000); chymotrypsin (molecular wt 25,000);
cytochrome C (molecular wt 12,000); and inulin (molecular wt
5,700). The column was equilibrated at 4°C with 0.1 M NaCI, 50
mM Tris-HCI buffer, pH 7.4 and samples were eluted at a flow
rate of 12 mI/hr. Fractions of 2 ml were collected, sterilized by
filtration and assayed for IL-l and TNF.
TNF and IL-l were measured in the supernatant of glomeruli
isolated from kidneys of five rabbits of Group I, five rabbits of
Group II, and five rabbits of Group VI 10 days after the i.v.
injection of BSA or saline. Ten thousand glomerulilml (1.14
0.4 mg proteins) were cultured for 24 hours with or without I
p,g/ml LPS and assayed. The biological activity obtained in the
TNF or in IL-I assay was abolished after absorption with
specific antibodies. The antiserum to TNFa was from Cetus
Corporation (Emeryville, California, USA). The antiserum to
IL-I was from Dr. C.A. Dinarello, Tufts University (Boston,
Massachusetts, USA). The specificity of these two antisera was
determined as previously described [23]. The biologically-
active fractions of TNF were eluted from Sephacryl S-200 with
an apparent molecular weight between 85 and 110 kd (corre-
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sponding to polymeric TNF under non-denaturating condi-
tions). IL-i-like activity had an apparent molecular weight
ranging between 12 and 19 kd, with a peak corresponding to 14
kd.
IL-I assay
IL-i-like activity was determined by its capacity to synergize
thymocyte proliferation induced by PHA [241. Briefly, macro-
phage depleted thymocytes obtained from neonatal C3H/HEJ
and C3H/HEN mice were plated in flat-bottomed microtiter
plates (500,000 cells/well) in complete medium with or without
0.5 g/ml PHA and twofold serial dilutions of supernatants to
be tested. After 48 hours of culture, the cells were pulsed with
1 Ci 3H-thymidine (2 mCi/mmol, Amersham). After 24 hours
of labelling, the medium was aspirated and 100 d of trypsin-
EDTA solution were added to each well. After an additional
incubation at 37°C for 10 minutes, the cells were harvested into
glass fiber filters and the 3H-thymidine incorporation was mea-
sured by liquid scintillation counting. Activity was expressed as
increments of mean counts of 3H-thymidine uptake by cells
from which the corresponding background (controls with PHA
only) was subtracted. Thymocyte proliferation in the presence
of RPMI with or without LPS was used as control, and showed
less than 10% variation from the mean in thymidine incorpora-
tion. As a reference, human recombinant IL-1f3 was used.
Samples positive for IL-l/3-like activity were also tested after
absorption with specific rabbit antibodies to human recombi-
nant IL-lp.
TNF assay
TNF was measured by a sensitive biological assay based on
the cytotoxic activity of the cytokine in the presence of an
inhibitor of protein synthesis [25]. Twofold serial dilutions of
samples were added together with 0.1 mg/mI of cycloheximide
to cultures of human SK-MEL-l09 melanoma cells sensitive to
the cytotoxic activity of TNF in concentrations as low as 20
pg/mi. These cells were grown as monolayers in 24-well cluster
plates, incubated with appropriate dilutions of samples, and
after 20 hours washed with PBS before staining with crystal
violet which was eluted and measured as described [26]. A
calibration curve was constructed with human recombinant
TNF to convert the cytotoxic activity of biological samples into
pglml of TNF. Furthermore, these samples were assayed on a
TNF-resistant cell line (designated R4) selected from SK-MEL-
109 cells as recently described for HeLa cells [27]. The lack of
cytotoxicity for TNF-resistant R4 cells in such control experi-
ments showed that the cell death, observed with sensitive
SK-MEL-109 cells, was specifically caused by TNF. In addi-
tion, TNF-dependent cytotoxicity was blocked by a rabbit
polyclonal anti-human recombinant TNFa antibody. The cyto-
toxicity assays were carried out in triplicate and gave a standard
error of < 5 percent.
Statistical analysis
The mean and standard deviation (± 1 SD) of all parameters
studied by light and fluorescence microscopy was calculated for
all groups of rabbits.
For statistical evaluation, data from Groups I, II, IV, V and
VI were entered in a database of an IBM computer, and
analyzed for statistical significance using BMDP3D one sample
Fig. 1. Urinary protein excretion from day 8 to day 15 are expressed as
mean (± I SD, vertical bars) of values detected in all rabbits within each
study group. Rabbits with AcSS and injected with PHA (Group II) or
with TNFa and IL-1/3 (Group V) had more proteinuria than rabbits with
AcSS (Group I). The Student's t-test was evaluated between: Group I
versus Group LI, Ill, IV and V respectively (**P < 0.001).
and two sample t-tests (BMDP, Statistical Software, Inc. Los
Angeles, California, USA). P values < 0.01 were considered
significant.
Results
Rabbits with AcSS (Group I)
Rabbits in Group I had modest, transient, (from day 10 to day
12) proteinuria (Fig. 1), and minimal reduction of the creatinine
clearance (the creatinine clearance of rabbits injected with
saline, Group VI, was 3.8 mI/mm/kg; Fig. 2). Granular deposits
of BSA and rabbit IgG (Fig. 3) were first detectable along the
glomerular basement membranes at day 8 and disappeared at
day 10 and day 15, respectively. Deposits of rabbit C3 were
detected at day 10, and were still present at time of sacrifice
(Fig. 4). Focal and segmental proliferative and exudative le-
sions were present in 40 to 50 percent of glomeruli, and reached
a peak at day 10. Maximum accumulation of PMN and of
mononuclear cells positive for non-specific esterase was ob-
served at day 8 and day 10, respectively (Fig, 5). Scattered
subepithelial deposits of foreign material (humps) were seen by
electron microscopy. Casts of proteinaceous material and cell
remnants were present in the lumens of some tubules. CHSO
activity of serum obtained at day 10 (7.5 2.0 U/ml) was
significantly reduced (P <0.01) in respect to basal values (day
0 23.1 5.8 U/mI) and to CH5O activity detected before

















1050 Camussi et a!: Leukocyte stimulation in immune complex GN
Fig. 4. Glomerular immune deposits evaluated by immunofluores-
cence technique from day 8 to day 15 are expressed as mean values (±
I SD) of the sum of scores given to sections stained for rabbit IgG, C3
and forBSA. Rabbits with AcSS and injected with PHA (Group II) had
less and different immune deposits than rabbits with AcSS (Group I).
Statistical analysis was performed between Group I and Groups II, III,
IV and V, respectively (** P < 0001).
granules between and within inflammatory cells (P < 0.001,
Figs. 4 and 7). About 80 percent of glomeruli had lesions that
were more severe than in glomeruli of rabbits of Group I (Fig.
5, P < 0.001), though the severity of these lesions varied from
glomerulus to glomerulus and from rabbit to rabbit. The most
striking feature was the infiltration of mononuclear cells (P <
0.001) and, to a lesser degree, of PMN in the lumens of the
capillaries, (Figs. 5, 8 and 9) and between the endothelium and
the peripheral basement membrane (Fig. 12). Some of these
cells resembled blast cells or activated large lymphocytes (Figs.
9, 10, 13).
Endothelial and mesangial cells were swollen and contained
an increased number of ribosomes. The lumens of the capillar-
ies were obliterated by infiltrated cells and swollen glomerular
cells, and the glomerular tufts had lobular aspects (Figs. 9, lfl.
Early obliteration of glomerular capillaries by inflammatory
cells, and increased phagocytosis, and/or a different state of
immune complex aggregation were probably responsible for the
decreased amount of immune deposits in the peripheral glomer-
ular capillary walls, as compared to rabbits in Group I, and for
the absence of subepithelial humps as seen by electron micros-
copy. Thrombi of fibrin (Fig. 10), fibrinoid necrosis (Fig. 11) and
tubular casts were more frequent than in rabbits of Group I (P

















Fig. 2. Creatinine clearance (± I si) in rabbits with AcSS (0, Group
I) and in rabbits with AcSS and injected with PHA (D. Group 11). The
mean creatinine clearance of rabbits injected with saline (Group VI)
was 3.8 mllmin/kg. Statistical significance was assessed between rabbits
of Group I and Group II (Kp < 0.01; ** < 0.001). A decreased
creatinine clearance persisted in rabbits of Group II 30 days after the
beginning of the experiment.
Fig. 3. Coarse granular deposits of rabbit IgG in the glomerular
capillary walls of a rabbit with AcSS without additional treatment
(Group I). x 600
and IL-i by isolated glomeruli unstimulated or stimulated with
LPS was only slightly increased as compared to rabbit injected
with isotonic saline (Group VI, Fig. 6).
Rabbits with AcSS and injected with PHA (Group II)
These rabbits had persistent proteinuria (Fig. 1, P < 0.001)
when compared to Group I and impairment of the creatinine
clearance (P < 0.01) until the end of the observation period
(Fig. 2). Glomerular immune deposits were significantly re-
duced and detectable at day 10 in form of fine fluorescent
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obtained at day 10 was comparable to that of Group I rabbits.
The amounts of TNF and IL-i produced by unstimulated
glomeruli were greater than in rabbits of Group I. After LPS
stimulation the production of these two cytokines increased
threefold (Fig. 6).
Rabbits with AcSS and injected with TNFa (Group III)
Proteinuria was slightly more elevated than in Group I (P =
NS), but considerably inferior than in Group II (P < 0.001) (Fig.
1). The results obtained by immunofluorescence technique were
similar to those obtained in Group II (Fig. 4). Glomerular
cellular infiltration was increased as compared to Group I (P <
0.001) but less diffuse than in Group II (Fig. 5). The signs of
endothelial cell activation and of interaction between endothe-
hal cells and mononuclear cells were indistinguishable from
those seen in rabbits of Group II. Intracapillary thrombi of
fibrin, fibrinoid necrosis and tubular casts were seen less
frequently than in Group II (Fig. 5)
Rabbits with AcSS and injected with IL-1/3 (Group IV)
Proteinuria was minimal (Fig. I). The amount of immune
deposits was greater than that seen in rabbits of Groups II and
III, but inferior to that present in Group I (Fig. 4). As in rabbits
Fig. 5. Semiquantitative evaluation of
glomerular lesions. Rabbits with AcSS and
injected with PHA (Group II) or with IL-lp and
TNFa (Group V) had more severe cellular
infiltration and fibrin thrombi than rabbits with
AcSS (Group I). The Student's (-test was
evaluated between Group I and Group II, III, IV
and V, respectively (* < 0.01; ** < 0.001).
Fig. 6. In each group ofrabbits the left
column indicates results obtained from
unstimulated glomeruli, and the right column
results obtained from glomeruli stimulated
with LPS. Stimulated glomeruli from kidneys
of rabbits with AcSS and injected with PHA
(Group II) produced more TNF than glomeruli
from rabbits with AcSS (Group I), or normal
rabbits (Group VI). Unstimulated and
stimulated glomeruli from kidneys of rabbits
in Group II produced more IL-I than
glomeruli from rabbits in Groups I and IV.
The Student's (-test was evaluated between:
Group VI versus Group I (+ P < 0.01); and
Group I versus Group II ("P < 0.01; <
0.001).
Fig. 7. Reduced amount and fine granular pattern of rabbit !gG(compare with Fig. 3) in a glomerulus of a rabbit with AcSS and
injected with PHA (Group II). x 600
of Group III these immune deposits were small and intercellu-
lar. The degree of glomerular infiltration of mononuclear cells
and PMN was more severe than in Group I and less severe than
in Group III (Fig. 5). The type of lesion was similar.
A Proliferation B No. PMNS C No. nonspecific D Fibrin
and x esterase- thrombi
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Fig. 8. Light micrograph showing diffuse pro! (feralive-exudative glomerulonephritis in a rabbit of Group 11. x 450
Fig. 9. Light micrograph illustrating the massive infiltration of mononuclear cells, probably, activated lymphocytes, in the glomerular capillaries
of a rabbit with AcSS and injected with PHA (Group II). X 1,000
Fig. 10. Light micrograph showing part of a
glomeru!us in a rabbit with AcSS and injected
with PHA. The arrowhead indicates a
thrombus of fibrin, and the arrow a pale large
granular mononuclear cell, probably a
lymphocyte. x 1,200
Fig. 11. Light micrograph. Fibrinoid necrosis
in a glomerulus of a rabbit with AcSS and
injected with PHA. x 1,200
Rabbits with AcSS and injected with TNF-a and IL-1f3
(Group V)
Proteinuria was increased as compared to rabbits in Group I
(P < 0.001), and was also superior to that measured in rabbits
of Groups III and IV (Fig. 1). As in rabbits of Groups II and III,
the amount of immune deposits was inferior to that of Group I
(Fig. 4). The glomerular lesions and the number of tubular casts
were more severe and more numerous than those observed in
Group I (P < 0.001), and similar to those seen in rabbits with
AcSS and injected with PHA (Group I!, Fig. 5).
Rabbits in Groups VI to X
The urinary protein excretion was normal. When examined
by morphological and immunohistochemical techniques, the
kidneys of these rabbits were consistently normal. Unstimu-
lated glomeruli obtained from rabbits injected with complete
Freund's adjuvants and isotonic saline (Group VI) did not
produce TNF, and produced 2.5 x 10 cpm of IL-I only. After
stimulation with LPS glomerular production of TNF and IL-I
was increased onefold (Fig. 6).
Discussion
Administration of PHA shortly before the immune clearance
of immune complexes increased the severity of morphologic
and functional changes in glomeruli of rabbits with experimen-
tal AcSS. Two observations suggest that after injection of PHA,
IL-i and TNF contribute to amplify the nephritogenic response.
First, lesions comparable to those induced by PHA occurred in
rabbits with AcSS and injected with IL-l/3 and TNFa. Second,
glomeruli isolated from kidneys of rabbits with AcSS and
injected with PHA produced more IL-l and TNF than glomeruli
of rabbits with AcSS and not injected with the mitogen. PHA
can, directly or indirectly, stimulate production of IL-I, inter-
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Fig. 12. Electron micrograph showing a glo,nerular capillary in a rabbit with AcSS and injected with PHA. A lymphocyte (L) has displaced the
endothelium and is in contact with the glomerular basement membrane (arrow). X indicates a cell that could be a swollen endothelial cell or part
of a macrophage. The asterisk indicates remnant of the endothelium. x 18,000
Fig. 13. Electron micrograph showing a glomerular capillary from a rabbit with AcSS and injected with PHA. L indicates a large lymphocyte. )(
20,000
PHA-stimulated mononuclear cells [28]. Likewise, IL-2 was
originally isolated from conditioned media of PHA-stimulated
lymphocytes [291. The stimulatory effect of PHA requires the
interaction of PHA with both monocytes and lymphocytes and
the production of IL-i and IL-2 [30]. TNF may result from
direct stimulation of monocyte because the mitogenic effect of
PHA is not restricted to lymphocytes [6]. Moreover, certain
cytokines are known to induce elaboration of other cytokines
[31]. IL-2 and mitogens, including PHA, stimulate the synthesis
of TNF [32] and interferon-a [33] which, in turn, promotes
expression of more TNF receptors [311.
The results of our experiments are concordant with other
observations suggesting that stimulation of synthesis and re-
lease, or direct administration, of proinflammatory cytokines
enhance the severity of glomerular lesions. LPS augmented
glomerular changes in rats injected with nephrotoxic serum
[34]. Small doses of IL-I and TNF enhanced the glomerular
lesions of rats with nephrotoxic glomerulonephritis [35], and of
mice with spontaneous lupus-like glomerulonephritis [36]. In
these experiments, as in our observations, the most pronounced
enhancing effect was obtained when IL-I and TNF were given
together [35], confirming that these two cytokines have syner-
gistic effects [37]. One explanation why PHA induced the
highest degree of enhancement is that this mitogen would
provoke synthesis of both IL-l, TNF and of other cytokines, so
that we examined the result of a stimulation exerted by multiple
polypeptide mediators. In agreement with this hypothesis is the
recent finding that IL-l/3 and TNFa increase mesangial cells
transcription of messenger RNA for interleukin-8 and monocyte
chemotactic protein-l, and the synthesis and release of inter-
leukin-6 [38], a lymphokine that in IL-6 transgenic mice [39] and
in man [40] is associated with development of proliferative
glomerulonephritis.
Injection of PHA, IL-I and TNF may exacerbate AcSS
glomerulonephritis by direct stimulation of glomerular cells and
resident [41] or infiltrated macrophages, or through a systemic
effect. Both IL-I and TNF activate the vascular endothelium in
vitro [42] and in vivo [43], including the glomerular endothelium
[44]. Endothelial activation consists of a number of responses
characterized by cell hypertrophy, increased expression of
class I and II histocompatibility antigens [42, 45—47], increase of
the adhesiveness of neutrophils, expression of pro-coagulant
molecules while, at the same time, the synthesis of plasminogen
activator is decreased [421. These changes may explain the
enhancement of the inflammatory lesions, including the forma-
tion of fibrin thrombi and fibrinoid necrosis in rabbits with AcSS
and injected with PHA, IL-lf and TNFa. IL-i, which can be
synthesized by activated mesangial cells [481, can also stimulate
them in a fashion similar to growth hormones [49] and promote
synthesis of TNF [50]. On the other hand, TNF induces
alteration of the glomerular endothelium, enhances intraglomer-
ular coagulation [511 and stimulate endothelial cells [521 and
macrophages [53] to produce IL-l. AcSS glomerulonephritis is
monocyte/macrophage-dependent [54]. IL-I could stimulate
monocyte resident [41] or infiltrated in glomeruli. Besides,
T-lymphocytes activated by IL-I secrete IFNa that, in turn,
induces macrophages to express class II antigens and other
indicators of activated state [42]. Thus, systemic injection of
PHA, IL-i/3 and TNFa could enhance the production of pro-
inflammatory peptides in glomeruli, in addition to any direct
effect that they may have on glomerular cells.
Glomerular infiltration of large lymphocytes morphologically
similar to natural killer (NK) cells or IL-2-activated lympho-
cytes [55] is seldom observed in experimental and human
glomerulonephritis. This peculiar cellular infiltration may be the
consequence of the stimulus of cytokines on NK cells and
CD8 + lymphocyte [56, 57], which could contribute to damage
glomerular endothelial and mesangial cells with their cytolytic
pore-forming protein [58].
In conclusion, the plant lectin mitogen PHA enhances the
severity of glomerular morphologic and functional changes in
rabbit with AcSS, increasing glomerular production of IL-i and
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TNF. Lectins are carbohydrate-binding proteins present in
pathogenic bacteria, viruses, and alimentary tract antigens [591
that could be associated with relapses or exacerbations of
glomerulonephritis. The results described are relevant to under-
standing how systemic infections, or infections at distal sites of
the body, exacerbate cell-mediated glomerular lesions [1, 61 by
a reaction broadly akin to the acute phase response [60].
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